Lupin Limited secures tentative FDA nod for generic Apalutamide Tablets
In a significant stride for global pharmaceuticals, Lupin Limited has garnered tentative approval from the United States Food and Drug Administration (U.S. FDA) to introduce its generic version of Apalutamide Tablets, 60 mg, echoing the renowned Erleada Tablets by Janssen Biotech, Inc. With an aim to tap into the vast US market, Lupin’s Abbreviated New […]